Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.
2.

Target hemoglobin level for EPO therapy in CKD.

Parfrey PS.

Am J Kidney Dis. 2006 Jan;47(1):171-3. No abstract available.

PMID:
16377399
3.

[Regarding the optimal hemoglobin target range in renal anemia].

Maurin N.

Med Klin (Munich). 2008 Sep 15;103(9):633-7. doi: 10.1007/s00063-008-1102-3. Epub 2008 Sep 24. Review. German.

PMID:
18813886
4.

Hypothesis versus association: the optimal hemoglobin target debate.

Strippoli GF, Craig JC.

Am J Kidney Dis. 2005 Nov;46(5):970-3. No abstract available.

PMID:
16253741
5.

Triumph and tragedy: anemia management in chronic kidney disease.

Novak JE, Szczech LA.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d. Review.

PMID:
18941350
6.

The target hemoglobin in non-dialysis CKD: still a matter for debate?

Kuriyama S.

Clin Exp Nephrol. 2010 Jun;14(3):298-9. doi: 10.1007/s10157-010-0280-5. Epub 2010 Mar 19. No abstract available.

PMID:
20300796
7.

Renal anemia: comparing current Eastern and Western European management practice (ORAMA).

Wiecek A, Covic A, Locatelli F, Macdougall IC; ORAMA study group.

Ren Fail. 2008;30(3):267-76. doi: 10.1080/08860220701857241.

PMID:
18350446
8.

Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?

Foley RN.

Clin J Am Soc Nephrol. 2006 Jul;1(4):678-84. Epub 2006 Jun 8. Review.

9.

[Anemia: guidelines comparison].

Del Vecchio L.

G Ital Nefrol. 2009 Nov-Dec;26(6):686-94. Italian.

PMID:
19918751
10.

Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.

Locatelli F, Covic A, Macdougall IC, Scherhag A, Wiecek A; ORAMA Study Group.

J Nephrol. 2009 Sep-Oct;22(5):662-74.

PMID:
19810000
11.

Anemia of chronic kidney disease: CHOIR and the FDA.

Singh AK.

Nat Clin Pract Nephrol. 2007 Aug;3(8):406-7. Epub 2007 Jun 26. No abstract available.

PMID:
17593919
12.

Anemia treatment in chronic kidney disease: shifting uncertainty.

Pfeffer MA.

Heart Fail Rev. 2008 Dec;13(4):425-30. doi: 10.1007/s10741-008-9087-9. Epub 2008 Apr 10. Review.

PMID:
18401704
13.

The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.

Singh AK.

Clin J Am Soc Nephrol. 2010 Apr;5(4):553-6. doi: 10.2215/CJN.00490110. Epub 2010 Mar 4. No abstract available.

14.

Hemoglobin levels, quality of life, and survival.

Sadler JH, Meyer KB.

Nephrol News Issues. 2007 Aug;21(9):42-3. Review. No abstract available.

PMID:
17722853
15.

Stability of target hemoglobin levels during the first year of epoetin treatment in patients with chronic kidney disease.

De Nicola L, Conte G, Chiodini P, Cianciaruso B, Pota A, Bellizzi V, Tirino G, Avino D, Catapano F, Minutolo R.

Clin J Am Soc Nephrol. 2007 Sep;2(5):938-46.

16.

Debate: CON Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?

Locatelli F, Del Vecchio L.

Am J Nephrol. 2010;31(6):557-60; discussion 561-2. doi: 10.1159/000314629. Epub 2010 May 21. No abstract available.

17.

[There are no differences between non-diabetics and diabetics with respect to the effect of anaemia correction in chronic kidney disease].

García López FJ.

Nefrologia. 2010;30(2):258-9. doi: 10.3265/Nefrologia.pre2010.Mar.10338. Spanish. No abstract available.

18.

Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?

Parfrey PS.

Am J Nephrol. 2010;31(6):565-6. doi: 10.1159/000313894. Epub 2010 May 21. No abstract available.

19.

[Anemia and cardiovascular risk in the chronic kidney disease population--which hemoglobin target should be reached?].

Krzesinski JM, Dubois B.

Rev Med Liege. 2007 May-Jun;62(5-6):366-70. Review. French.

PMID:
17725208
20.

Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management.

Gallagher MP, Cass A, Craig JC.

Nephrology (Carlton). 2010 Jun;15(4):429-33. doi: 10.1111/j.1440-1797.2010.01300.x. Review.

PMID:
20609094

Supplemental Content

Support Center